These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33390269)

  • 1. Elevated NK-cell transcriptional signature and dysbalance of resting and activated NK cells in atopic dermatitis.
    Möbus L; Rodriguez E; Harder I; Schwarz A; Wehkamp U; Stölzl D; Boraczynski N; Gerdes S; Litman T; Kleinheinz A; Abraham S; Heratizadeh A; Handrick C; Haufe E; Schmitt J; Werfel T; Weidinger S;
    J Allergy Clin Immunol; 2021 May; 147(5):1959-1965.e2. PubMed ID: 33390269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atopic dermatitis displays stable and dynamic skin transcriptome signatures.
    Möbus L; Rodriguez E; Harder I; Stölzl D; Boraczynski N; Gerdes S; Kleinheinz A; Abraham S; Heratizadeh A; Handrick C; Haufe E; Werfel T; Schmitt J; Weidinger S;
    J Allergy Clin Immunol; 2021 Jan; 147(1):213-223. PubMed ID: 32615169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma.
    Badi YE; Pavel AB; Pavlidis S; Riley JH; Bates S; Kermani NZ; Knowles R; Kolmert J; Wheelock CE; Worsley S; Uddin M; Alving K; Bakke PS; Behndig A; Caruso M; Chanez P; Fleming LJ; Fowler SJ; Frey U; Howarth P; Horváth I; Krug N; Maitland-van der Zee AH; Montuschi P; Roberts G; Sanak M; Shaw DE; Singer F; Sterk PJ; Djukanovic R; Dahlen SE; Guo YK; Chung KF; Guttman-Yassky E; Adcock IM;
    J Allergy Clin Immunol; 2022 Jan; 149(1):89-101. PubMed ID: 33891981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.
    Guttman-Yassky E; Bissonnette R; Ungar B; Suárez-Fariñas M; Ardeleanu M; Esaki H; Suprun M; Estrada Y; Xu H; Peng X; Silverberg JI; Menter A; Krueger JG; Zhang R; Chaudhry U; Swanson B; Graham NMH; Pirozzi G; Yancopoulos GD; D Hamilton JD
    J Allergy Clin Immunol; 2019 Jan; 143(1):155-172. PubMed ID: 30194992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers.
    He H; Olesen CM; Pavel AB; Clausen ML; Wu J; Estrada Y; Zhang N; Agner T; Guttman-Yassky E
    Front Immunol; 2020; 11():1768. PubMed ID: 32849633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between NK cells and ILC cells and their subsets in atopic dermatitis patients with and without dupilumab therapy.
    Boudkova P; Čermáková E; Krejsek J; Čelakovská J
    Int Immunopharmacol; 2024 Jul; 136():112327. PubMed ID: 38820963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.
    Hamilton JD; Suárez-Fariñas M; Dhingra N; Cardinale I; Li X; Kostic A; Ming JE; Radin AR; Krueger JG; Graham N; Yancopoulos GD; Pirozzi G; Guttman-Yassky E
    J Allergy Clin Immunol; 2014 Dec; 134(6):1293-1300. PubMed ID: 25482871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate-to-severe atopic dermatitis.
    Hartmann J; Moitinho-Silva L; Sander N; Harder I; Häsler R; Rodriguez E; Haufe E; Kleinheinz A; Abraham S; Heratizadeh A; Weisshaar E; Schäkel K; Handrick C; Augustin M; Wollenberg A; Staubach-Renz P; Ertner K; Sticherling M; Schwarz B; Quist S; Wiemers F; Schenck F; Wildberger J; Tittmann L; Lieb W; Schmitt J; Werfel T; Weidinger S;
    Allergy; 2023 Aug; 78(8):2290-2300. PubMed ID: 37032440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
    Ariëns LFM; Gadkari A; van Os-Medendorp H; Ayyagari R; Terasawa E; Kuznik A; Chen Z; Bégo-Le Bagousse G; Lu Y; Rizova E; Graham NMH; Pirozzi G; De Bruin-Weller M; Eckert L
    Acta Derm Venereol; 2019 Sep; 99(10):851-857. PubMed ID: 31099402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities.
    He H; Del Duca E; Diaz A; Kim HJ; Gay-Mimbrera J; Zhang N; Wu J; Beaziz J; Estrada Y; Krueger JG; Pavel AB; Ruano J; Guttman-Yassky E
    J Allergy Clin Immunol; 2021 Apr; 147(4):1369-1380. PubMed ID: 33011244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senescent fibroblasts and innate immune cell activation might play a role in the pathogenesis of elderly atopic dermatitis.
    Luo Y; Fang X; Zhou Y; Zhang Y; Li W; Leng SX; Yao X; Liu X
    J Dermatol Sci; 2024 Jun; 114(3):94-103. PubMed ID: 38806324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood mononuclear cell- transcriptome signatures of atopic dermatitis and prediction for the efficacy of dupilumab.
    Wang Y; Wu Y; Gu C; Wang S; Yin H; Zhu R; Wang C; Li Z; Yao X; Li W
    J Dermatol Sci; 2023 Sep; 111(3):83-92. PubMed ID: 37349237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of acute-to-chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responses.
    Tsoi LC; Rodriguez E; Stölzl D; Wehkamp U; Sun J; Gerdes S; Sarkar MK; Hübenthal M; Zeng C; Uppala R; Xing X; Thielking F; Billi AC; Swindell WR; Shefler A; Chen J; Patrick MT; Harms PW; Kahlenberg JM; Perez White BE; Maverakis E; Gudjonsson JE; Weidinger S
    J Allergy Clin Immunol; 2020 May; 145(5):1406-1415. PubMed ID: 31891686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis.
    He H; Suryawanshi H; Morozov P; Gay-Mimbrera J; Del Duca E; Kim HJ; Kameyama N; Estrada Y; Der E; Krueger JG; Ruano J; Tuschl T; Guttman-Yassky E
    J Allergy Clin Immunol; 2020 Jun; 145(6):1615-1628. PubMed ID: 32035984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonlesional atopic dermatitis skin shares similar T-cell clones with lesional tissues.
    Brunner PM; Emerson RO; Tipton C; Garcet S; Khattri S; Coats I; Krueger JG; Guttman-Yassky E
    Allergy; 2017 Dec; 72(12):2017-2025. PubMed ID: 28599078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.
    Khattri S; Shemer A; Rozenblit M; Dhingra N; Czarnowicki T; Finney R; Gilleaudeau P; Sullivan-Whalen M; Zheng X; Xu H; Cardinale I; de Guzman Strong C; Gonzalez J; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2014 Jun; 133(6):1626-34. PubMed ID: 24786238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of High and Low IFNG-Expressing Subgroups in Atopic Dermatitis.
    Wasserer S; Jargosch M; Mayer KE; Eigemann J; Raunegger T; Aydin G; Eyerich S; Biedermann T; Eyerich K; Lauffer F
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With Dupilumab.
    Mikhaylov D; Del Duca E; Olesen CM; He H; Wu J; Ungar B; Estrada Y; Zhang N; Chowdhury M; Clausen ML; Krueger JG; Pavel AB; Agner T; Guttman-Yassky E
    Dermatitis; 2021 Oct; 32(1S):S71-S80. PubMed ID: 34405829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis.
    Callewaert C; Nakatsuji T; Knight R; Kosciolek T; Vrbanac A; Kotol P; Ardeleanu M; Hultsch T; Guttman-Yassky E; Bissonnette R; Silverberg JI; Krueger J; Menter A; Graham NMH; Pirozzi G; Hamilton JD; Gallo RL
    J Invest Dermatol; 2020 Jan; 140(1):191-202.e7. PubMed ID: 31252032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral natural killer cells exhibit qualitative and quantitative changes in patients with psoriasis and atopic dermatitis.
    Luci C; Gaudy-Marqueste C; Rouzaire P; Audonnet S; Cognet C; Hennino A; Nicolas JF; Grob JJ; Tomasello E
    Br J Dermatol; 2012 Apr; 166(4):789-96. PubMed ID: 22233261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.